← Back to Intelligence
// TOPIC PROFILE
3.8.4
Gene Technologies
Analytical deep dive — question counts, mark distribution, mastery curves, command-word breakdowns, and examiner narrative analysis.
Questions
36
Total marks
70
Marks / Q
1.9
Accessibility
47.5%
Mastery
27.3%
Student strength
32.9%
01
At a glance
3.8.4 · Gene Technologies
8YRSYNTHESIS
3.8.4 (Gene Technologies) appeared in 8 of the 8 years between 2017 and 2024, contributing 36 questions and 70 marks across Papers 1, 2 and 3. APPLICATION dominates the mark distribution at 50.0% of total marks. The accessibility–mastery gap sits at 20.2 percentage points (47.5% vs 27.3%) — most students reach partial credit, but full marks remain harder to secure. Mastery varied year-to-year, lowest in 2022 (20.8%) and highest in 2023 (32.0%). Calculation marks are a small share (5.7%) but typically sit at the lower end of the mastery distribution.
Access–mastery gap
+20 pp
Lowest mastery
2022 · 20.8%
Highest mastery
2024 · 32.0%
02
Question type split
By marks · compound to dominant
70MARKS
70
marks
Application50.0%35 marks
Knowledge44.3%31 marks
Calculation5.7%4 marks
(by marks; compound rows assigned to dominant type):
03
Credit terms — quick reference
Mark scheme tier-locked
25TERMS
Tier 1 · Always credit
restriction endonucleasephosphodiester bondsprimerselectrophoresis
Tier 2 · Sometimes credit
DNA polymerasenucleotidesrestriction enzymemasshybridisationrecognition siterestriction sitecompare positionsticky endsPCRautoradiography
Reject · Never credit
stop codontRNAhydrogen bonds (for polymerase action)making DNA single-stranded alonenucleotide sourceDNA helicase denaturedDNA base sequences in virusessize/density (too vague)'only own cells used' (not equivalent to 'donors not required')labelled probe only (not sufficient for definition); marker gene (different thing)
04
Question patterns
Recurring formats & tariff structure
0PARAGRAPHS
05
Year-over-year presence
P1 + P3 · 2017–2024
8YEARS
| Year | Questions | Total marks | Mean accessibility | Mean mastery |
|---|---|---|---|---|
| 2017 | 7 | 11 | 44.1% | 29.6% |
| 2018 | 2 | 4 | 56.5% | 24.5% |
| 2019 | 6 | 11 | 52.5% | 24.7% |
| 2020 | 5 | 9 | — COVID | — COVID |
| 2021 | 3 | 10 | — COVID | — COVID |
| 2022 | 5 | 10 | 38.6% | 20.8% |
| 2023 | 4 | 8 | 57.2% | 32.0% |
| 2024 | 4 | 7 | 42.8% | 32.0% |
06
Mark scheme intelligence
2017–2024 mark scheme corpus
30TERMS
Tier 1 — frequently credited
| Term | Times credited | Years | Notes |
|---|---|---|---|
| restriction endonuclease | 5 | 2018, 2022, 2023, 2024 | |
| phosphodiester bonds | 3 | 2017, 2019, 2024 | |
| primers | 3 | 2017, 2021, 2023 | |
| electrophoresis | 3 | 2021, 2022, 2024 |
Tier 2 — sometimes credited
| Term | Times credited | Years | Notes |
|---|---|---|---|
| DNA polymerase | 3 | 2017, 2023 | |
| nucleotides | 3 | 2017, 2021 | |
| restriction enzyme | 2 | 2018, 2023 | |
| mass | 2 | 2018, 2023 | |
| hybridisation | 2 | 2019, 2022 | |
| recognition site | 2 | 2019, 2023 | |
| restriction site | 2 | 2019, 2023 | |
| compare position | 2 | 2019, 2024 | |
| sticky ends | 2 | 2020, 2024 | |
| PCR | 2 | 2020, 2022 | |
| autoradiography | 2 | 2020, 2021 |
Commonly rejected language
| Term | Times rejected | Years | Why rejected |
|---|---|---|---|
| stop codon | 2 | 2017, 2022 | |
| tRNA | 1 | 2017 | |
| hydrogen bonds (for polymerase action) | 1 | 2017 | |
| making DNA single-stranded alone | 1 | 2017 | |
| nucleotide source | 1 | 2017 | |
| DNA helicase denatured | 1 | 2017 | |
| DNA base sequences in viruses | 1 | 2017 | |
| size/density (too vague) | 1 | 2018 | |
| 'only own cells used' (not equivalent to 'donors not required') | 1 | 2019 | |
| labelled probe only (not sufficient for definition); marker gene (different thing) | 1 | 2019 | |
| DNA helicase; DNA polymerase; reverse transcriptase; heating to break DNA | 1 | 2019 | |
| to replicate DNA; for RNA transcription; 'to expose bases' alone (without stating probe can then bind) | 1 | 2019 | |
| 'control lane' without specifying known sizes; fragments contain different numbers of VNTRs; RNA in lane 1 | 1 | 2019 | |
| more than three volunteer numbers given (right + wrong = wrong rule) | 1 | 2019 | |
| restriction enzymes cuts the gene | 1 | 2020 |
Marks in this sub-section are typically awarded for precise terminology and correct application of biological principles. Sequential mark schemes — where each mark requires building on the previous one — are common in multi-mark questions; stating the first step without progression rarely earns more than one mark. Calculation marks are typically split between method (correct setup and value extraction) and answer (accurate numerical result), allowing partial credit when arithmetic errors occur.
07
Where students lose marks
Examiner-anchored error patterns
4CASE STUDIES
Conceptual errors
- Reversing the direction of reverse transcriptase — the enzyme converts mRNA into cDNA; a common error describes it as making RNA from DNA, confusing it with RNA polymerase or transcription
- Swapping restriction endonucleases and DNA ligase: naming helicase, DNA polymerase, or reverse transcriptase instead of restriction endonuclease for cutting, or omitting ligase entirely from cloning descriptions
- Assuming bacteria can produce human proteins directly from genomic DNA — bacteria lack the spliceosome machinery to remove introns; cDNA (produced from processed mRNA via reverse transcriptase) must be used
- Believing a DNA probe can only locate a gene if that gene has been expressed — probes work by complementary base pairing with extracted single-stranded DNA regardless of expression status
- Stating that bacteria "have only uracil" when asked why they cannot produce functional human proteins — bacteria have DNA with thymine exactly like eukaryotes; the correct answer involves splicing, Golgi processing, or transcription factor availability
Vocabulary errors
- "Hydrogen bonds" for the activity of DNA ligase or DNA polymerase — these enzymes form phosphodiester bonds between nucleotides; hydrogen bonds form between complementary base pairs and are not the backbone linkage
- "Size" or "density" for the basis of electrophoresis separation — "mass" or "length/number of base pairs" is required; "size alone" was explicitly rejected in 2018
- "Labelled probe only" as a definition of a DNA probe — the definition requires single-stranded DNA with a complementary base sequence to the target gene; labelling is a detection feature, not the structural definition
- "Marker gene" used interchangeably with "gene probe" — marker genes confirm that transformation has occurred; probes locate specific target sequences in extracted DNA; these are distinct tools
- "Stop codon reached" as the reason PCR stops — the PCR plateau occurs because primers or nucleotides are exhausted, or Taq polymerase eventually denatures; stop codons operate in translation, not in PCR
Application errors
- On gene therapy evaluation questions: describing the method of gene therapy step by step rather than evaluating the conclusion — the evaluative framing requires identifying specific advantages and limitations relative to the comparator treatment
- On electrophoresis band-counting questions: miscounting the number of fragments produced by a given set of restriction cuts (drawing 4 or 6 bands when 5 are produced) or drawing vertical rather than horizontal banding patterns
- On DNA screening procedure questions: naming the correct components (PCR, restriction endonuclease, electrophoresis, probe, detection) without ordering them into a logical sequence — mark schemes for multi-step procedures require the correct order, not just component recall
- On cDNA synthesis questions: naming reverse transcriptase and mRNA correctly but omitting that existing DNA in the sample must be removed or destroyed before RT-PCR, or failing to state explicitly why (otherwise endogenous DNA would be amplified alongside the cDNA)
High-impact failures · examiner narrative
2017 P2 Q08.32 marks
Approximately 3% mastery, with 80% of students scoring zero — the sharpest failure point in this subtopic. The question asked why DNA in a sample is hydrolysed before RT-PCR. The two required ideas were: (1) to remove any existing DNA so it cannot be amplified alongside the cDNA made from RNA, and (2) the mark scheme required students to explicitly state that DNA is removed or destroyed, not just implied. The dominant wrong answers were that hydrolysis breaks hydrogen bonds to make DNA single-stranded for primer binding (wrong — this confuses the purpose of thermal denaturation in PCR with enzymatic hydrolysis), and that hydrolysis provides an extra source of nucleotides for PCR. Students who came close — suggesting that only RNA would then lead to amplification — were not credited unless they clearly stated the DNA was removed.
2022 P2 Q10.24 marks
Approximately 5% mastery. Students recalled individual components correctly but consistently failed to connect them into a logical sequence. The required procedure was: PCR to amplify the sample → restriction endonuclease to cut DNA into fragments → electrophoresis to separate fragments → labelled DNA probes added, hybridising to complementary sequences → detection by fluorescence, radioactivity, or autoradiography → comparison to known banding pattern. Responses that named PCR and probes without sequencing the full procedure earned at most two marks. The mark scheme treated each procedural step as a separate mark point, so component knowledge without sequential logic capped students well below full marks.
2019 P2 Q02.33 marks
Approximately 5% mastery, with fewer than two-thirds of students scoring even one mark. The question required evaluation of gene therapy versus HSCT for SCD, meaning arguments both for and against gene therapy. Most students provided only arguments in favour, missing that sickle cell red blood cells continue to be produced from existing bone marrow during gene therapy (not an advantage), that no bone marrow destruction occurs (an advantage that was rarely identified), and that "only own cells used" is not equivalent to "donors are not required" and was explicitly rejected. Students who described the method of gene therapy instead of evaluating the conclusion against HSCT scored zero on the evaluative marks.
2022 P3 Q04.62 marks
Approximately 6% mastery, with the highest non-attempt rate in the subtopic at 8%. The question asked for two reasons why a tissue-specific enhancer active only in mammary glands is important for commercial antithrombin production. The two credited answers were: (1) milk is easy to extract from a goat without harm, and (2) if antithrombin were expressed in blood rather than milk, it would prevent blood clotting, which is harmful. The second mark point — that antithrombin is an anticoagulant and its presence in blood would be dangerous — was the critical piece of applied biology most students missed. Students who described the GM process correctly, or repeated that expression was tissue-specific, scored nothing for restating what the question had already told them.
08
Difficulty signals
Performance metric synthesis
20PP GAP
Mean accessibility
47.5%
Mean mastery
27.3%
Mean student strength
32.9%
The accessibility–mastery gap of 20.2 percentage points characterises this sub-section's difficulty profile. Most students reach partial credit; full marks remain harder to achieve. Within 3.8 (The control of gene expression), 3.8.4 ranks 2 of 4 sub-sections by mean mastery (1 = hardest). Mastery trajectory is broadly flat across the cohort window: 29.6% in 2017 → 32.0% in 2024 (+2.4 percentage points). Mean mastery was lowest in 2022 (20.8%) and highest in 2023 (32.0%).